Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of determining patient populations amenable to immunomodulatory treatment of cancer

Methods of determining patient populations amenable to immunomodulatory treatment of cancer

US Patent 11215616 · Granted Jan 4, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Disease-associated antigens and methods of use thereof2024
Disease-associated antigens and methods of use thereof2024
Methods of identifying and treating patient populations amenable to cancer immun2023
Disease-associated antigens and methods of use thereof2021
Disease-associated antigens and methods of use thereof2021
Disease-associated antigens and methods of use thereof2018
Disease-associated antigens and methods of use thereof2018
Prostatitis-associated antigens and methods of use thereof2015
Adjuvant treatment by in vivo activation of dendritic cells2002